Both CHIP and AgeAccelHG+ were associated with increased risk of coronary heart disease and all‐cause mortality (although the results did not reach statistical significance ( p = 0.077) for CHIP and all‐cause mortality), and the risk was highest in the 40% of CHIP carriers who also had age acceleration (CHIP+/AgeAccelHG+).
← all excerpts
Ageing Through the Looking-Glass: The Different Flavours of Clonal Haematopoiesis.
1
0.0770
0.0770